首页/数据集/Supplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States

Supplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States

NIAID Data Ecosystem2026-04-30 收录

化疗耐药机制

JAK–STAT信号通路

数据链接：

https://figshare.com/articles/dataset/Supplementary_Table_S2_from_JAK_STAT_Signaling_in_Inflammatory_Breast_Cancer_Enables_Chemotherapy-Resistant_Cell_States/22432923 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Table S2

应用场景：

创建时间：

2023-01-18

化疗耐药机制

表观遗传药物干预

Characterization of histone 3 lysine 4 and lysine 27 trimethylation changes upon development of taxane-platin drug resistance in NSCLC cells and evaluation of these histone modifications after treatme

NIAID Data Ecosystem40

RAS-mutant AML LSCs originate from GMPs and drive clinical resistance to BH3 mimetics [RNA-Seq]. RAS-mutant AML LSCs originate from GMPs and drive clinical resistance to BH3 mimetics [RNA-Seq]

白血病干细胞

化疗耐药机制

Cancer driver mutations often show distinct temporal acquisition patterns, but the biological basis for this, if any, remains unknown. RAS mutations occur invariably late in the course of acute myeloi

NIAID Data Ecosystem00

NUDT5 restrains PPAT to promote pyrimidine synthesis and effective nucleobase therapy - sgNUDT5 proteomics

核苷酸代谢调控

化疗耐药机制

Nucleotides are essential building blocks for nucleic acid synthesis, signaling, and metabolism. Rapidly proliferating cells require large amounts of nucleotides, making nucleotide metabolism a widely

NIAID Data Ecosystem00

Supplementary Table S3 from Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer

化疗耐药机制

抗癌药物筛选

Results of secondary screening for compounds that suppress 5-FU-induced GFP expression in ALDH1A3-GFP cells

NIAID Data Ecosystem20

Phosphorylated RB represses the transcriptional activity of ETS1 to modulate the sensitivity of prostate cancer cells to CDK4/6 inhibitors [CUT&Tag]

化疗耐药机制

表观遗传调控

CDK4/6 inhibitors are potential drugs for PCa treatment. Exploring underlying mechanism of cquired resistance to CDK4/6 inhibitors a is very important for the clinical application of these drugs. In t

NIAID Data Ecosystem00

Supplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States

资源简介：

相关数据集